|Phase of Study:||Phase II|
|Treatment Location:||Both at MDACC & outside MDACC at one or more Collaborating Sites or Institutions|
|Estimated Length of Stay in Houston:||N/A|
|Return Visit:||RAD001 will be taken daily fm Visit 2, Day 1until disease progression or |
unacceptable toxicity or discontinuation from the study for any other reason.
On days when PK sample collection is performed, study drug administration will
occur at the clinic.
|Home Care:||Patients will be instructed to take RAD001 at the same time each day, 10 mg|
orally once daily (qd), two 5 mg tablets at once (one tablet after another)
with a glass of water.